Rather than defining an arbitary timepoint beyond which they shouldn't be allowed to quote survival stats...i'd like to see a law where they are not allowed to quote beyond the time point where say the p-value goes over 0.05. That way a better powered trial with more patients and more events can quote longer in time than a lower powered trial even though they might have the same median follow-up.
Market Data 
Markets 
AI
